Compare Amylx Pharmaceuticals Inc (AMLX) vs Infosys Limited (INFY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Infosys Limited — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Infosys Limited trades at $12.36 (market cap $50.55B). The key difference: Infosys Limited is far larger — about 19.1× Amylx Pharmaceuticals Inc's market cap, and Infosys Limited pays a 4.16% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | INFY | |
|---|---|---|
Market Cap | $2.64B | $50.55B |
Sector | Health | Technology |
52-Week High | $24.19 | $20.22 |
52-Week Low | $7.82 | $10.49 |
Enterprise Value | $2.39B | $48.30B |
Dividend Yield | — | 4.16% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →
